ATRA
Atara Biotherapeutics Inc
Price:  
0.78 
USD
Volume:  
5,434,742.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atara WACC - Weighted Average Cost of Capital

The WACC of Atara Biotherapeutics Inc (ATRA) is 7.4%.

The Cost of Equity of Atara Biotherapeutics Inc (ATRA) is 7.40%.
The Cost of Debt of Atara Biotherapeutics Inc (ATRA) is 7.00%.

Range Selected
Cost of equity 6.40% - 8.40% 7.40%
Tax rate -% - -% -%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.4% - 8.3% 7.4%
WACC

Atara WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.55 0.62
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 8.40%
Tax rate -% -%
Debt/Equity ratio 0.05 0.05
Cost of debt 7.00% 7.00%
After-tax WACC 6.4% 8.3%
Selected WACC 7.4%